Does medication adherence lower Medicare spending among beneficiaries with diabetes?
about
The effect of copayments for prescriptions on adherence to prescription medicines in publicly insured populations; a systematic review and meta-analysisAssessing medication adherence and healthcare utilization and cost patterns among hospital-discharged patients with schizoaffective disorder.The association between nonadherence and glycated hemoglobin among type 2 diabetes patients using basal insulin analogsIncident user cohorts for assessing medication cost-offsetsAntipsychotic adherence patterns and health care utilization and costs among patients discharged after a schizophrenia-related hospitalizationMedication adherence and readmission after myocardial infarction in the Medicare populationImpact of consumer copayments for subsidised medicines on health services use and outcomes: a protocol using linked administrative data from Western AustraliaReal-world outcomes of US employees with type 2 diabetes mellitus treated with insulin glargine or neutral protamine Hagedorn insulin: a comparative retrospective database studyA renewed Medication Adherence Alliance call to action: harnessing momentum to address medication nonadherence in the United States.Simulated value-based insurance design applied to statin use by Medicare beneficiaries with diabetes.Adherence and health care costs.Healthy adherer effect - the pitfall in the interpretation of the effect of medication adherence on health outcomes.Cross-cultural adaptation of The Beliefs about Medicines Questionnaire into Portuguese.Association of copayment and statin adherence stratified by socioeconomic status.Estimating the Impact of Oral Diabetes Medication Adherence on Medical Costs in VA.
P2860
Q26829072-D0E4B14A-3BF9-4EB0-B514-6092ED61CAD9Q33633758-EB97D0F9-E766-4484-826E-DA84D673AE62Q33800715-E864A36B-A1C5-4E49-9628-9ECDC6B8B7C6Q34553899-233CDEA0-988F-4551-8508-EC0DC44CF4B2Q35008229-BF9EB89D-F956-437D-97FA-AA6A819FD363Q35063975-DB53F92F-EEA5-48E8-AF9C-C6FE693BCFA6Q36411739-48B9665C-C6F2-4881-8E60-325EA694EA60Q36809906-A865620C-D020-4105-A4A4-44696FD10E82Q37082805-1F7DD85D-C851-4596-9181-521FA4502CEAQ37394557-CF77FA13-5E60-4963-8888-0810428AABCBQ37603117-A631EBDC-AE21-4B01-B284-9F48CA5E168BQ38159780-4BCCA90A-F254-4519-B48E-6CC34DC490AEQ44019984-496B260C-5D73-4BF9-B1A5-F248F6882B07Q46120468-F9B6628E-7F81-4B13-AC64-7FBEC9FAFF8FQ48290678-307C00A7-9275-47DB-B61F-E7E3A1E6C1DA
P2860
Does medication adherence lower Medicare spending among beneficiaries with diabetes?
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Does medication adherence lower Medicare spending among beneficiaries with diabetes?
@ast
Does medication adherence lower Medicare spending among beneficiaries with diabetes?
@en
type
label
Does medication adherence lower Medicare spending among beneficiaries with diabetes?
@ast
Does medication adherence lower Medicare spending among beneficiaries with diabetes?
@en
prefLabel
Does medication adherence lower Medicare spending among beneficiaries with diabetes?
@ast
Does medication adherence lower Medicare spending among beneficiaries with diabetes?
@en
P2093
P2860
P1476
Does medication adherence lower Medicare spending among beneficiaries with diabetes?
@en
P2093
Amy Davidoff
Bruce Stuart
J Samantha Shoemaker
Jennifer Lloyd
Ruth Lopert
Thomas Shaffer
P2860
P304
P356
10.1111/J.1475-6773.2011.01250.X
P577
2011-03-17T00:00:00Z